David A. Gonyer
Net Worth

Last updated:

What is David A. Gonyer net worth?

The estimated net worth of Mr. David A. Gonyer is at least $6,439,961 as of 14 Dec 2020. He owns shares worth $1,943,553 as insider, has earned $209,758 from insider trading and has received compensation worth at least $4,286,650 in Evoke Pharma, Inc..

What is the salary of David A. Gonyer?

Mr. David A. Gonyer salary is $857,330 per year as Co-Founder, Chief Executive Officer, Pres & Director in Evoke Pharma, Inc..

How old is David A. Gonyer?

Mr. David A. Gonyer is 61 years old, born in 1964.

What stocks does David A. Gonyer currently own?

As insider, Mr. David A. Gonyer owns shares in one company:

Company Title Shares Price per share Total value
Evoke Pharma, Inc. (EVOK) Co-Founder, Chief Executive Officer, Pres & Director 339,782 $5.72 $1,943,553

What does Evoke Pharma, Inc. do?

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

David A. Gonyer insider trading

Evoke Pharma, Inc.

Mr. David A. Gonyer has made 2 insider trades in 2020, according to the Form 4 filled with the SEC. Most recently he sold 23,954 units of EVOK stock worth $70,425 on 14 Dec 2020.

The largest trade he's ever made was exercising 72,000 units of EVOK stock on 9 Dec 2020. As of 14 Dec 2020 he still owns at least 339,782 units of EVOK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 23,954 $2.94 $70,425
Sale
Common Stock 48,046 $2.9 $139,333
Option
Stock Option (Right to Buy) 72,000 $0.4 $28,800
Option
Common Stock 72,000 $0.4 $28,800

Evoke Pharma key executives

Evoke Pharma, Inc. executives and other stock owners filed with the SEC: